United States · Bill · S
S. 2608 (115th)
Reducing Opioid Risk Act
Introduced
22 March 2018
Last action
22 March 2018 · Introduced
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
Elizabeth Warren, Shelley Capito
Subjects
Healthcare
Source updated
11 August 2025
Summary
Reducing Opioid Risk Act This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to require a drug manufacturer to inform health care providers about state and federal regulations for controlled substances, including the partial fill option.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
22 March 2018
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
22 March 2018
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 22 March 2018 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 22 March 2018
Introduced in Senate (PDF)
Introduced in Senate · EN · 22 March 2018
Introduced in Senate
summary · EN · 22 March 2018
Sponsors
- Elizabeth Warren · D · Sponsor
- Shelley Capito · R · Sponsor
- · sshr00 · Standing
Related records
- related to ← Opioid Crisis Response Act of 2018
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/2608
- Open data entity: https://api.congress.gov/v3/bill/115/s/2608
- us · 115-s-2608 · source updated 11 August 2025